Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 507)
Posted On: 05/05/2020 5:16:19 AM
Post# of 155138
Avatar
Posted By: Sunny3999
One more in American Institute of Chemical Engineers Journals!

Employing Drug Delivery Strategies to Create Safe and Effective Pharmaceuticals for COVID‐19
Kevin J. McHugh
First published:29 April 2020

Abstract (incl. Leronlimab):
There are also a number of post-infection therapeutics being evaluated in the clinic for their potential ability to reduce the severity of COVID-19.22,23 Most of these drugs are repurposed small molecule antivirals and immune-modulating antibodies either already approved for other indications (e.g. chloroquine, hydroxychloroquine, ribavirin, favipiravir) while others have progressed through early stage clinical trials, but have not yet received FDA approval (e.g. remdesivir, galidesivir, leronlimab ). While there are numerous reports of their in vitro efficacy, their therapeutic value for humans remains unclear at present. With COVID-19 spreading at an alarming rate and the FDA helping to facilitate safety and efficacy testing, some of these drug trials.

https://aiche.onlinelibrary.wiley.com/doi/epd...btm2.10163

logo-header-1554102594807.png













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site